United Therapeutics (UTHR) reported Q4 net income Wednesday of $6.19 per diluted share, up from $4.36 a year earlier.
Analysts polled by FactSet expected $6.35.
Revenue for the quarter ended Dec. 31 was $735.9 million, down from $614.7 million a year earlier.
Analysts surveyed by FactSet expected $734.7 million.
Shares of the company were up more than 2% in recent Wednesday premarket activity.
Price: 365.90, Change: +8.40, Percent Change: +2.35
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。